liraglutide vs semaglutide

liraglutide (S-tier) vs semaglutide (S-tier). mechanism, trials, evidence boundaries, dosing literature. side-by-side reference.

liraglutide — tier S

A once-daily GLP-1 receptor agonist sold under separate Saxenda and Victoza labels.

Liraglutide has direct obesity, diabetes, cardiovascular, and adolescent evidence, with daily dosing and product-specific labels.

8.4 kg SCALE mean weight change · half-life ~13 hours · weight loss

semaglutide — tier S

A GLP-1 receptor agonist with current US injection and oral products for distinct labeled uses.

Strong obesity, cardiovascular, kidney, and MASH evidence, but each result belongs to its own product, route, population, and label.

14.9% STEP 1 mean weight change · half-life ~1 week · weight loss

at a glance

• liraglutide: tier S · 8.4 kg SCALE mean weight change
• semaglutide: tier S · 14.9% STEP 1 mean weight change

reptides grades the research record and cites the literature behind every call. research reference only; not medical advice.